Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:07:41 EDT Mon 14 Oct 2024
Enter Symbol
or Name
USA
CA



Q:ENGN - ENGENE HOLDINGS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ENGN - Q5.27.57·8.151.27.72+0.537.4132.39833417.26  7.72  7.0843.00  4.4216:09:38Oct 0115 min RT 2¢

Recent Trades - Last 10 of 341
Time ETExPriceChangeVolume
16:09:38Q7.800.611
16:00:00Q7.720.5317
16:00:00Q7.720.5331
16:00:00Q7.720.534
16:00:00Q7.720.5313
16:00:00Q7.720.536
16:00:00Q7.720.539
16:00:00Q7.720.53600
16:00:00Q7.720.53100
16:00:00Q7.720.53300

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-10-01 16:05U:ENGNNews ReleaseenGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2024-09-26 06:30U:ENGNNews ReleaseDetalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort
2024-09-10 16:33U:ENGNNews ReleaseenGene Reports Third Quarter 2024 Financial Results and Provides a Business Update
2024-08-28 16:05U:ENGNNews ReleaseenGene to Participate in Upcoming Investor Conferences
2024-07-24 16:05U:ENGNNews ReleaseenGene Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2024-07-24 06:30U:ENGNNews ReleaseenGene Announces Appointment of Ron Cooper as Chief Executive Officer
2024-07-18 08:00U:ENGNNews ReleaseNewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors
2024-06-14 07:01U:ENGNNews ReleaseenGene Reports Second Quarter 2024 Financial Results and Provides a Business Update
2024-05-29 07:30U:ENGNNews ReleaseenGene to Present at the Jefferies Global Healthcare Conference
2024-05-15 16:05U:ENGNNews ReleaseenGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors
2024-05-02 16:05U:ENGNNews ReleaseenGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting
2024-04-09 08:56U:ENGNNews Release/C O R R E C T I O N -- enGene Inc./
2024-04-09 08:31U:ENGNNews ReleaseenGene Announces Hiring of Dr. Raj Pruthi as Senior Vice President, Urologic Oncology and Clinical Development
2024-04-09 08:25U:ENGNNews ReleaseenGene Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical Development
2024-04-09 08:00U:ENGNNews Releaseengender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical Development
2024-03-11 17:16U:ENGNNews ReleaseenGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress
2024-03-05 07:00U:ENGNNews ReleaseenGene To Present at the Leerink Partners Global Biopharma Conference
2024-02-14 06:50U:ENGNNews ReleaseenGene Announces Oversubscribed $200 Million Private Placement Financing
2024-02-14 06:45U:ENGNNews ReleaseenGene Announces Leadership Succession Plan
2024-01-30 07:00U:ENGNNews ReleaseenGene Appoints Lee Giguere as Chief Legal Officer and Corporate Secretary